Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Mode of action and mechanisms of resistance for antimalarial drugs.

Olliaro P.

Pharmacol Ther. 2001 Feb;89(2):207-19. Review.

PMID:
11316521
2.

Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro.

Canfield CJ, Pudney M, Gutteridge WE.

Exp Parasitol. 1995 May;80(3):373-81.

PMID:
7729473
3.

[Mechanism of action of antimalarials. Value of combined atovaquone/proguanil].

Touze JE, Fourcade L, Pradines B, Hovette P, Paule P, Heno P.

Med Trop (Mars). 2002;62(3):219-24. Review. French.

PMID:
12244914
4.

The mode of action and the mechanism of resistance to antimalarial drugs.

Foote SJ, Cowman AF.

Acta Trop. 1994 Mar;56(2-3):157-71. Review.

PMID:
8203302
5.

[Combined antimalarial therapy using artemisinin].

Majori G.

Parassitologia. 2004 Jun;46(1-2):85-7. Review. Italian.

PMID:
15305693
6.

Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.

Muehlen M, Schreiber J, Ehrhardt S, Otchwemah R, Jelinek T, Bienzle U, Mockenhaupt FP.

Trop Med Int Health. 2004 Mar;9(3):361-3.

PMID:
14996365
7.

Antimalarial drugs: modes of action and mechanisms of parasite resistance.

Müller IB, Hyde JE.

Future Microbiol. 2010 Dec;5(12):1857-73. doi: 10.2217/fmb.10.136. Review.

PMID:
21155666
8.

Antimalarial chemotherapy: young guns or back to the future?

Biagini GA, O'Neill PM, Nzila A, Ward SA, Bray PG.

Trends Parasitol. 2003 Nov;19(11):479-87. Review. No abstract available.

PMID:
14580958
10.

Pharmacodynamic interaction between atovaquone and other antimalarial compounds against Plasmodium falciparum in vitro.

Lütgendorf C, Rojanawatsirivet C, Wernsdorfer G, Sirichaisinthop J, Kollaritsch H, Wernsdorfer WH.

Wien Klin Wochenschr. 2006;118(19-20 Suppl 3):70-6.

PMID:
17131244
11.

New trends in anti-malarial agents.

Frédérich M, Dogné JM, Angenot L, De Mol P.

Curr Med Chem. 2002 Aug;9(15):1435-56. Review.

PMID:
12173975
12.

Antimalarial compounds: from bench to bedside.

Olliaro PL, Taylor WR.

J Exp Biol. 2003 Nov;206(Pt 21):3753-9. Review.

13.

The new drug combinations: their place in the treatment of uncomplicated Plasmodium falciparum malaria.

Danis M, Bricaire F.

Fundam Clin Pharmacol. 2003 Apr;17(2):155-60. Review.

PMID:
12667225
14.

Antimalarial drug development and new targets.

Macreadie I, Ginsburg H, Sirawaraporn W, Tilley L.

Parasitol Today. 2000 Oct;16(10):438-44. Review.

PMID:
11006476
16.

Artemisinin and chloroquine: do mode of action and mechanism of resistance involve the same protagonists?

Lelièvre J, Berry A, Benoit-Vical F.

Curr Opin Investig Drugs. 2007 Feb;8(2):117-24. Review.

PMID:
17328227
17.

Recent advances in antimalarial compounds and their patents.

Mital A.

Curr Med Chem. 2007;14(7):759-73. Review.

PMID:
17346161
18.

Plasmodium falciparum outwits Malarone, protector of travellers.

Crabb C.

Bull World Health Organ. 2003;81(5):382-3. Epub 2003 Jul 7. No abstract available.

19.

Drug resistance hampers our capacity to roll back malaria.

Olliaro P.

Clin Infect Dis. 2005 Aug 15;41 Suppl 4:S247-57. Review.

PMID:
16032560
20.

Antimalarial drug synergism and antagonism: mechanistic and clinical significance.

Bell A.

FEMS Microbiol Lett. 2005 Dec 15;253(2):171-84. Epub 2005 Oct 7. Review.

Supplemental Content

Support Center